Remote Monitored Systems PLC (LON:RMS) has said its Gyrometric business is “well positioned” to meet the challenges of UK technologies services required to achieve an increase in the country’s offshore wind turbine capacity proposed by prime minister Boris Johnson earlier this week.
In an update late on Thursday afternoon, the AIM-listed company said Gyrometric is continuing detailed technical discussions with one of the world's largest manufacturers of offshore wind turbines about the installation and testing of the company’s technology on a large wind turbine in early in 2021.
READ: Remote Monitored Systems expects substantial revenues from P2F's face masks
The testing is aiming to prove that Gyrometric’s laser system will provide monitoring of important parameters not previously measurable on a rotating turbine or in the field on extremely large and powerful wind turbines.
“The Gyrometric system is entirely designed and manufactured in the UK, and so, we believe, the business is well-positioned to meet the challenge of UK technological services being central to the increase in wind turbine capacity as posed in the recent prime ministerial announcement”, Remote Monitored Systems said in a statement.
Pharm 2 Farm update
Elsewhere in the update, Remote Monitored Systems also referred to the update on Thursday from Braveheart Investment Group PLC (LON:BRH) which noted that Pharm 2 Farm Limited (P2F), one of Braveheart’s investee companies, has revealed that there has been a short delay in the planned testing of its anti-viral face mask material.
READ: Braveheart Investment notes short delay in planned testing of investee firm, Pharm 2 Farm's anti-viral face mask material
In its statement, Braveheart said the Health and Safety Executive (HSE) and its Advisory Committee on Dangerous Pathogens, had revised the policy on working with coronavirus and has scheduled an inspection at the test facility where P2F is conducting its trials. This has had the consequential effect of delaying the trial while HSE undertake an inspection of the CL-3 laboratory to ensure all the appropriate safeguards are in place.
Remote Monitored Systems noted that it has previously signed a binding share agreement to purchase P2F from Braveheart, with the firm saying it expects to update shareholders on the acquisition later this month.
Shares in RMS were 3% lower at 0.6p in mid-morning deals on Friday.
--Adds share price--